trial · primary record
Ritlecitinib
Celiac Disease
| Phase | Phase 2 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 62 |
| Primary completion | 2026-04-09 |
| Primary endpoint | Change in Small Intestinal Histology based on Vh:Cd ratio |
| Registry ID | NCT05636293 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:42:04.959Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05636293
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.